A.D. Shapiro

502 total citations
11 papers, 352 citations indexed

About

A.D. Shapiro is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, A.D. Shapiro has authored 11 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in A.D. Shapiro's work include Hemophilia Treatment and Research (5 papers), Platelet Disorders and Treatments (3 papers) and Blood groups and transfusion (3 papers). A.D. Shapiro is often cited by papers focused on Hemophilia Treatment and Research (5 papers), Platelet Disorders and Treatments (3 papers) and Blood groups and transfusion (3 papers). A.D. Shapiro collaborates with scholars based in United States, Canada and Greece. A.D. Shapiro's co-authors include M. J. Manco‐Johnson, Victor S. Blanchette, Pia Petrini, Kathelijn Fischer, Paul Giangrande, Jan Astermark, Sven Björkman, Ray F. Kilcoyne, Erik Berntorp and W. Schramm and has published in prestigious journals such as Blood, Haemophilia and Journal of Pediatric Ophthalmology & Strabismus.

In The Last Decade

A.D. Shapiro

9 papers receiving 342 citations

Peers

A.D. Shapiro

HEMAT

GENET

MB

SURGE

EMS

Kerry Hege United States

Maj Carlsson Sweden

Julio del Río-Garma Spain

Jennifer Perry United States

Nicoletta Revelli Italy

Deanna Duvall United States

Dalia Bashari Israel

Lisa Lima United States

Tito Roccia United States

A. Griškevičius Lithuania

Kerry Hege United States

A.D. Shapiro

79 ×0.2

HEMAT

13 ×0.2

GENET

28 ×0.6

MB

12 ×0.5

SURGE

8 ×0.4

EMS

Citations per year, relative to A.D. Shapiro A.D. Shapiro (= 1×) peers Kerry Hege

Countries citing papers authored by A.D. Shapiro

Since Specialization

Citations

This map shows the geographic impact of A.D. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.D. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.D. Shapiro more than expected).

Fields of papers citing papers by A.D. Shapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.D. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.D. Shapiro. The network helps show where A.D. Shapiro may publish in the future.

Co-authorship network of co-authors of A.D. Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of A.D. Shapiro. A scholar is included among the top collaborators of A.D. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.D. Shapiro. A.D. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Shapiro, A.D., et al.. (2025). Care Team Assistants as a Strategy to Reduce Physicians’ Administrative Task Burden. Hospital Pediatrics. 15(4). e143–e147.

2.

Alzahrani, Hazzaa, Adam Cuker, Όλγα Κατσαρού, et al.. (2023). PB0186 Results from BeneGene-1 Study: Prospective Collection of Bleeding Rate in Hemophilia B Patients Prior to Phase 3 Study (BeneGene-2) of Fidanacogene Elaparvovec. Research and Practice in Thrombosis and Haemostasis. 7. 101217–101217. 1 indexed citations

3.

Mahlangu, Johnny, A.D. Shapiro, John Pasi, et al.. (2017). Individualised Prophylaxis with Recombinant Factor IX FC Fusion Protein (RFIXFC) in Adults/Adolescents With Haemophilia B: Updated Interim Results of the B-YOND Extension Study. Murdoch Research Repository (Murdoch University). 1 indexed citations

4.

Windyga, Jerzy, M. V. Ragni, John Pasi, et al.. (2015). Subject-Reported Changes in Physical Activity During The B-LONG Study of Recombinant Factor IX FC Fusion Protein (RFIXFC) For Severe Haemophilia B. Queen Mary Research Online (Queen Mary University of London). 1 indexed citations

5.

Haberichter, Sandra L., et al.. (2013). Variability in platelet‐ and collagen‐binding defects in type 2M von Willebrand disease. Haemophilia. 19(4). 590–594. 24 indexed citations

6.

Bellissimo, Daniel B., Thomas C. Abshire, W. Keith Hoots, et al.. (2007). Novel VWF Sequence Variations Identified in Normal Controls and Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD).. Blood. 110(11). 709–709. 1 indexed citations

7.

Haberichter, Sandra L., Pamela A. Christopherson, Patricia A. Morateck, et al.. (2007). The Prevalence of Reduced VWF Survival Phenotype (Type 1C VWD) in Type 1 Index Cases Recruited into the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB - VWD).. Blood. 110(11). 2133–2133.

8.

Ewenstein, Bruce M., Leonard A. Valentino, Michael D. Tarantino, et al.. (2004). Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia. 10(5). 629–648. 86 indexed citations

9.

Berntorp, Erik, Jan Astermark, Sven Björkman, et al.. (2003). Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia. 9(s1). 1–4. 218 indexed citations

10.

Evatt, Bruce L., Albert Farrugia, A.D. Shapiro, & J Wilde. (2002). Haemophilia 2002: emerging risks of treatment. Haemophilia. 8(3). 221–229. 17 indexed citations

11.

Shapiro, A.D., et al.. (1979). Visual Functions Following Bilateral Surgery of Congenital Cataracts in Children. Journal of Pediatric Ophthalmology & Strabismus. 16(3). 176–179. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact